Keywords: gsk, initiates, trial, cervarix, vs, merck, gardasil
GSK's initiates trial of Cervarix vs Merck's Gardasil
Article | 22 January 2007
UK drug major GlaxoSmithKline has initiated a head-to-head trial of its cervical cancer vaccine Cervarix versus Merck & Co's competitor Gardasil, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
